The following pages link to Layla Parast (Q95335):
Displaying 30 items.
- Tianxi Cai (Q75169) (← links)
- Evaluation of longitudinal surrogate markers (Q95343) (← links)
- longsurr (Q95344) (← links)
- (Q95372) (redirect page) (← links)
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q95375) (← links)
- OSsurvival (Q95376) (← links)
- Estimation of the proportion of treatment effect explained by a high‐dimensional surrogate (Q95492) (← links)
- Robust approach to combining multiple markers to improve surrogacy (Q95742) (← links)
- (Q118765) (redirect page) (← links)
- Using a surrogate marker for early testing of a treatment effect (Q118767) (← links)
- SurrogateTest (Q118768) (← links)
- (Q118835) (redirect page) (← links)
- Quantifying the bias due to observed individual confounders in causal treatment effect estimates (Q118837) (← links)
- SBdecomp (Q118838) (← links)
- (Q118839) (redirect page) (← links)
- Assessing the value of a censored surrogate outcome (Q118842) (← links)
- SurrogateOutcome (Q118843) (← links)
- Evaluating incremental values from new predictors with net reclassification improvement in survival analysis (Q746472) (← links)
- Landmark estimation of survival and treatment effects in observational studies (Q2356620) (← links)
- Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information (Q4904726) (← links)
- Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial (Q4975358) (← links)
- Evaluating Incremental Values from New Predictors with Net Reclassification Improvement in Survival Analysis (Q4984857) (← links)
- Using a surrogate marker for early testing of a treatment effect (Q5121040) (← links)
- Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker (Q5222223) (← links)
- Incorporating short‐term outcome information to predict long‐term survival with discrete markers (Q5391159) (← links)
- Flexible evaluation of surrogate markers with Bayesian model averaging (Q5977129) (← links)
- Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
- Robust methods to correct for measurement error when evaluating a surrogate marker (Q6055522) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Discussion of “A Risk-Based Measure of Time-Varying Prognostic Discrimination for Survival Models,” by C. Jason Liang and Patrick J. Heagerty (Q6079968) (← links)
